SUCRALIX O
SUCRALFATE 1000 MG + OXETACAINE 20 MG MG SYP
Brand: SUCRALIX O
MRP
₹350/-
Packaging
200 ML WITH CARTON
Form
ANTA-ACID
Description & Usage
Sucralfate 1000 MG, Oxetacaine 20 MG Syp
Sucralfate 1000 MG, Oxetacaine 20 MG Syp is a pharmaceutical oral suspension preparation which is formulated using both Sucralfate and Oxetacaine. This is considered as one of the strong combination oral products under the gastrocare / general medicine products range. Sucralfate 1000mg and Oxetacaine 20mg combined forms a very strong oral suspension which possesses the qualities and value to the respective firms marketing such kind of digestive care medicines.
This formulation should be available in the list of medicines manufactured by a company operating in PCD pharma franchise, third party manufacturing of medicines or branded medicines marketing / distribution etc. Being an oral liquid formulation it has very easy packaging, storage and distribution facility for any of the pharma channel. With adequate manufacturing standards, effective product packaging and guaranteed availability Sucralfate 1000 MG, Oxetacaine 20 MG Syp would form an integral part of any professional gastrocare range.
Composition Profile and Suspension Formulation Value
Each oral liquid contains Sucralfate 1000 mg and Oxetacaine 20 mg as the chief constituent of the formula. Sucralfate 1000 mg has the most acceptable identity for all the gastrocare compositions available and Oxetacaine 20 mg makes the overall formulation even more marketable with strong and relevant product profile. The combination of the above makes a strong product for the formulation manufacturers of medicine and for any pharma company working with gastrocare medicines ranges.
The suspension is formulated by using an adequate ratio of pharmaceutical grade excipients like sweeteners, flavors, stabilizers, preservatives and suspension supporting agents that maintain an appropriate taste, texture, viscosity and shelf life of the medicine. These agents also play a very important role in keeping the formula and every dose in the medicine uniformly mixed together.
Gastrocare Product Identity and Market Position
The identity of the product Sucralfate 1000 MG, Oxetacaine 20 MG Syp is very firm in the gastrocare medicine product section. Oral liquids for gastrocare medicines are included in almost every pharma company’s portfolio of medicine due to its strong product value and constant market presence. With such a medicine, a company can form an entire gastrocare medicine set including antacid syrups, capsules, gels, enzyme preparations, liver tonics and other supplements.
Oral suspension formulations are attractive when branded well. They make the product more appealing to even prescribers of medicine due to their aesthetic appearance and unique product positioning. Branding of Sucralfate 1000 MG, Oxetacaine 20 MG Syp may include eye-catchy bottle design and an artistic outer carton with a clear product constitution mentioned on the bottle. A company can position the product as a strong gastrocare oral suspension in product literature andvisual aids.
Quality Manufacturing and Processing Standards
The production and manufacturing of Sucralfate 1000 MG, Oxetacaine 20 MG Syp demand a very hygienic manufacturing environment with high production standards and strict quality controls. Only the quality focused firms that manufacture with standard and pure raw materials, automated liquid filling machines, high capacity blenders, clean and efficient production areas can produce the formulation with desired purity, strength, shelf life and uniformity. Any manufacturing stage should be done under technical supervision.
Each batch should be monitored through out from the quality aspect right from testing of raw materials, preparation of the suspension base to blending uniformity of the formulation, uniformity of the active ingredients in the final product and ultimately packaging. As it is a dual combination formula it is necessary that the active ingredients remain uniform in every 5ml or 10ml of the formulated medicine, therefore, high quality blending machine is essential.
Standard production with Good Manufacturing Practices is also essential to make the formulation available to the doctors and wholesalers on a consistent batch to batch basis, thus building the trust of the distributors and the company itself in the market.
Packaging, Labeling and Brand Presentation
The packaging of Sucralfate 1000 MG, Oxetacaine 20 MG Syp needs to be perfect and of good quality to maintain the integrity and look of the product. Generally this product comes in a 100ml bottle or 200ml bottle, enclosed in a neatly printed outer carton with a suitable measuring cap and measuring scale given along with the bottle. An effective packaging keeps the suspension protected from atmospheric exposure, leakage, contamina-tion, light, etc during its transit.
The product label and outer carton should clearly display the name of the medicine brand name, common names and respective salt constitutions along with dosage, quantity, date of manufacturing and expiry date of the formulation,MRP of the product and other such information. It is also crucial to write down the company details along with their logo and other important instructions required. Attractive, well printed labels with adequate product information add on to the professional brand presentation and appearance of the medicine.
Branding aspect is equally significant as attractive product labeling enhances the product value in the market and provides the product with an esteemed place in comparison to its competitors.
Market Demand and PCD Pharma Franchise Scope
The demand for Sucralfate 1000 MG, Oxetacaine 20 MG Syp is always there in the market as the oral gastrocare compositions are one of the commonly prescribed medicines across the board in general medicines. With the introduction of this combination, a firm can have a substantial and very valuable addition in their digestive care medicine range.
This product is considered to be a high value product by the wholesalers and distributors as this medicine has to be procured in good quantity. A strong addition to the existing product list of the PCD pharma franchise company adds significant value and support to the overall functioning of a pharma distributor or retailer. Many companies who are associated with PCD pharma franchise often include this formulation as it completes their range of medicines. Besides gastrocare it can be combined with antacids, other supplements etc. To make the range extensive.
The scope for the PCD pharma franchise business is huge and this particular medicine also has considerable business value to the company selling it on a franchise basis. It can be made available through extensive marketing using visuals aids, product cards, reminder cards, prescription pads, and various MR bags along with other material and a strong and reliable supply chain with guaranteed timely delivery. The brand presentation, standard manufacturing practices and a guarantee of product availability along with rights over a specific territory would further help in making Sucralfate 1000 MG, Oxetacaine 20 MG Syp a substantial part of a professionally organized PCD pharma franchise company.
Sucralfate 1000 MG, Oxetacaine 20 MG Syp
Sucralfate 1000 MG, Oxetacaine 20 MG Syp is a pharmaceutical oral suspension preparation which is formulated using both Sucralfate and Oxetacaine. This is considered as one of the strong combination oral products under the gastrocare / general medicine products range. Sucralfate 1000mg and Oxetacaine 20mg combined forms a very strong oral suspension which possesses the qualities and value to the respective firms marketing such kind of digestive care medicines.
This formulation should be available in the list of medicines manufactured by a company operating in PCD pharma franchise, third party manufacturing of medicines or branded medicines marketing / distribution etc. Being an oral liquid formulation it has very easy packaging, storage and distribution facility for any of the pharma channel. With adequate manufacturing standards, effective product packaging and guaranteed availability Sucralfate 1000 MG, Oxetacaine 20 MG Syp would form an integral part of any professional gastrocare range.
Composition Profile and Suspension Formulation Value
Each oral liquid contains Sucralfate 1000 mg and Oxetacaine 20 mg as the chief constituent of the formula. Sucralfate 1000 mg has the most acceptable identity for all the gastrocare compositions available and Oxetacaine 20 mg makes the overall formulation even more marketable with strong and relevant product profile. The combination of the above makes a strong product for the formulation manufacturers of medicine and for any pharma company working with gastrocare medicines ranges.
The suspension is formulated by using an adequate ratio of pharmaceutical grade excipients like sweeteners, flavors, stabilizers, preservatives and suspension supporting agents that maintain an appropriate taste, texture, viscosity and shelf life of the medicine. These agents also play a very important role in keeping the formula and every dose in the medicine uniformly mixed together.
Gastrocare Product Identity and Market Position
The identity of the product Sucralfate 1000 MG, Oxetacaine 20 MG Syp is very firm in the gastrocare medicine product section. Oral liquids for gastrocare medicines are included in almost every pharma company’s portfolio of medicine due to its strong product value and constant market presence. With such a medicine, a company can form an entire gastrocare medicine set including antacid syrups, capsules, gels, enzyme preparations, liver tonics and other supplements.
Oral suspension formulations are attractive when branded well. They make the product more appealing to even prescribers of medicine due to their aesthetic appearance and unique product positioning. Branding of Sucralfate 1000 MG, Oxetacaine 20 MG Syp may include eye-catchy bottle design and an artistic outer carton with a clear product constitution mentioned on the bottle. A company can position the product as a strong gastrocare oral suspension in product literature andvisual aids.
Quality Manufacturing and Processing Standards
The production and manufacturing of Sucralfate 1000 MG, Oxetacaine 20 MG Syp demand a very hygienic manufacturing environment with high production standards and strict quality controls. Only the quality focused firms that manufacture with standard and pure raw materials, automated liquid filling machines, high capacity blenders, clean and efficient production areas can produce the formulation with desired purity, strength, shelf life and uniformity. Any manufacturing stage should be done under technical supervision.
Each batch should be monitored through out from the quality aspect right from testing of raw materials, preparation of the suspension base to blending uniformity of the formulation, uniformity of the active ingredients in the final product and ultimately packaging. As it is a dual combination formula it is necessary that the active ingredients remain uniform in every 5ml or 10ml of the formulated medicine, therefore, high quality blending machine is essential.
Standard production with Good Manufacturing Practices is also essential to make the formulation available to the doctors and wholesalers on a consistent batch to batch basis, thus building the trust of the distributors and the company itself in the market.
Packaging, Labeling and Brand Presentation
The packaging of Sucralfate 1000 MG, Oxetacaine 20 MG Syp needs to be perfect and of good quality to maintain the integrity and look of the product. Generally this product comes in a 100ml bottle or 200ml bottle, enclosed in a neatly printed outer carton with a suitable measuring cap and measuring scale given along with the bottle. An effective packaging keeps the suspension protected from atmospheric exposure, leakage, contamina-tion, light, etc during its transit.
The product label and outer carton should clearly display the name of the medicine brand name, common names and respective salt constitutions along with dosage, quantity, date of manufacturing and expiry date of the formulation,MRP of the product and other such information. It is also crucial to write down the company details along with their logo and other important instructions required. Attractive, well printed labels with adequate product information add on to the professional brand presentation and appearance of the medicine.
Branding aspect is equally significant as attractive product labeling enhances the product value in the market and provides the product with an esteemed place in comparison to its competitors.
Market Demand and PCD Pharma Franchise Scope
The demand for Sucralfate 1000 MG, Oxetacaine 20 MG Syp is always there in the market as the oral gastrocare compositions are one of the commonly prescribed medicines across the board in general medicines. With the introduction of this combination, a firm can have a substantial and very valuable addition in their digestive care medicine range.
This product is considered to be a high value product by the wholesalers and distributors as this medicine has to be procured in good quantity. A strong addition to the existing product list of the PCD pharma franchise company adds significant value and support to the overall functioning of a pharma distributor or retailer. Many companies who are associated with PCD pharma franchise often include this formulation as it completes their range of medicines. Besides gastrocare it can be combined with antacids, other supplements etc. To make the range extensive.
The scope for the PCD pharma franchise business is huge and this particular medicine also has considerable business value to the company selling it on a franchise basis. It can be made available through extensive marketing using visuals aids, product cards, reminder cards, prescription pads, and various MR bags along with other material and a strong and reliable supply chain with guaranteed timely delivery. The brand presentation, standard manufacturing practices and a guarantee of product availability along with rights over a specific territory would further help in making Sucralfate 1000 MG, Oxetacaine 20 MG Syp a substantial part of a professionally organized PCD pharma franchise company.